Prometheus Biosciences Price Prediction
| RXDXDelisted Stock | USD 199.92 0.24 0.12% |
Oversold Vs Overbought
85
Oversold | Overbought |
Using Prometheus Biosciences hype-based prediction, you can estimate the value of Prometheus Biosciences from the perspective of Prometheus Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Prometheus Biosciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Prometheus because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Prometheus Biosciences after-hype prediction price | USD 199.92 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prometheus |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Prometheus Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Prometheus Biosciences After-Hype Price Prediction Density Analysis
As far as predicting the price of Prometheus Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Prometheus Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Prometheus Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Prometheus Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Prometheus Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Prometheus Biosciences' historical news coverage. Prometheus Biosciences' after-hype downside and upside margins for the prediction period are 199.92 and 199.92, respectively. We have considered Prometheus Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Prometheus Biosciences is very steady at this time. Analysis and calculation of next after-hype price of Prometheus Biosciences is based on 3 months time horizon.
Prometheus Biosciences Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Prometheus Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Prometheus Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Prometheus Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 9 Events / Month | 14 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
199.92 | 199.92 | 0.00 |
|
Prometheus Biosciences Hype Timeline
Prometheus Biosciences is at this time traded for 199.92. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Prometheus is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Prometheus Biosciences is about 0.0%, with the expected price after the next announcement by competition of 199.92. About 17.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 3.54. Prometheus Biosciences had not issued any dividends in recent years. The entity had 1:100 split on the 1st of November 2013. Given the investment horizon of 90 days the next forecasted press release will be in about 9 days. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.Prometheus Biosciences Related Hype Analysis
Having access to credible news sources related to Prometheus Biosciences' direct competition is more important than ever and may enhance your ability to predict Prometheus Biosciences' future price movements. Getting to know how Prometheus Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Prometheus Biosciences may potentially react to the hype associated with one of its peers.
Prometheus Biosciences Additional Predictive Modules
Most predictive techniques to examine Prometheus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Prometheus using various technical indicators. When you analyze Prometheus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Prometheus Biosciences Predictive Indicators
The successful prediction of Prometheus Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Prometheus Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Prometheus Biosciences based on analysis of Prometheus Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Prometheus Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Prometheus Biosciences's related companies.
Story Coverage note for Prometheus Biosciences
The number of cover stories for Prometheus Biosciences depends on current market conditions and Prometheus Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Prometheus Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Prometheus Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Prometheus Biosciences Short Properties
Prometheus Biosciences' future price predictability will typically decrease when Prometheus Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Prometheus Biosciences often depends not only on the future outlook of the potential Prometheus Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Prometheus Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 40.6 M | |
| Cash And Short Term Investments | 695.8 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Prometheus Stock
If you are still planning to invest in Prometheus Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Prometheus Biosciences' history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |